Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Cash from Investing Activities: 2019-2024

Historic Cash from Investing Activities for Praxis Precision Medicines (PRAX) over the last 5 years, with Dec 2024 value amounting to -$248.5 million.

  • Praxis Precision Medicines' Cash from Investing Activities rose 1.71% to $50.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 102.66%. This contributed to the annual value of -$248.5 million for FY2024, which is 737.98% down from last year.
  • Latest data reveals that Praxis Precision Medicines reported Cash from Investing Activities of -$248.5 million as of FY2024, which was down 737.98% from $39.0 million recorded in FY2023.
  • Praxis Precision Medicines' 5-year Cash from Investing Activities high stood at $96.9 million for FY2022, and its period low was -$248.5 million during FY2024.
  • For the 3-year period, Praxis Precision Medicines' Cash from Investing Activities averaged around -$37.6 million, with its median value being $39.0 million (2023).
  • In the last 5 years, Praxis Precision Medicines' Cash from Investing Activities surged by 168.95% in 2022 and then plummeted by 737.98% in 2024.
  • Praxis Precision Medicines' Cash from Investing Activities (Yearly) stood at -$140.5 million in 2021, then spiked by 168.95% to $96.9 million in 2022, then plummeted by 59.80% to $39.0 million in 2023, then slumped by 737.98% to -$248.5 million in 2024.